Results 221 to 230 of about 92,303 (298)
Engineering intrinsically radiolabeled nanoparticles for imaging and therapy: a decade of design strategies and insights. [PDF]
Ghosh S, Chakravarty R.
europepmc +1 more source
Through AI‐assisted screening from FDA‐approved API to overcome the limitations of bacterial osteomyelitis treatment, glycyrrhizic acid and simvastatin are identified as a multifunctional combination capable of self‐assembling into mechanism‐targeting nanocrystals that effectively neutralize reactive oxygen species, suppress M1 macrophage polarization,
Yu Han +11 more
wiley +1 more source
Disease mechanisms and translational barriers guide nanocarrier design for nose to brain delivery in Alzheimer's disease. [PDF]
Liao C, Sun D, Wang X.
europepmc +1 more source
A programmable encapsulation technology is developed to reduce bacterial immunogenicity and proliferation after systemic administration. The cross‐linked polymer networks around individual bacteria enable immunogenic shielding and permit selective proliferation in tumors, allowing the bacteria to convert tumor‐accumulated ammonia into L‐arginine and ...
Jianhui Yang +12 more
wiley +1 more source
In Vivo Fate of Diatom-Based Nanocarriers: Advances, Challenges, and Future Perspectives. [PDF]
Naik K, De Stefano L, Rea I.
europepmc +1 more source
Systemic platelet factor 4 (PF4) is significantly depleted in amyotrophic lateral sclerosis (ALS). Peripheral PF4 replenishment restores central proteostasis by driving OPTN‐dependent, PINK1‐independent selective autophagy in motor neurons. This intervention effectively clears toxic SOD1 aggregates, blunts glial activation, and preserves neuromuscular ...
Qingjian Xie +12 more
wiley +1 more source
Diagnostic performance of [<sup>18</sup>F]Tetrafluoroborate PET versus <sup>131</sup>I scintigraphy in differentiated thyroid cancer: a prospective study. [PDF]
Sonmezoglu K +6 more
europepmc +1 more source
A high‐loading Zn single‐atom nanozyme (ZMG@CS) delivers ML‐SA5 and GOx to lysosomes. ML‐SA5 activates TRPML1 to release endogenous Zn2+, while the nanozyme provides exogenous Zn2+ and GOx‐driven acidification amplifies ROS production. Together, these effects suppress the HIF‐1α/GLUT1 axis, disrupt glucose and redox homeostasis, induce disulfidptosis ...
Zhenxin Wang +12 more
wiley +1 more source
Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration. [PDF]
Schuderer F +11 more
europepmc +1 more source

